Chemo-Light trio offers hope for older lymphoma patients
NCT ID NCT05798156
First seen Apr 08, 2026 · Last updated May 01, 2026 · Updated 4 times
Summary
This study tests a new drug combination for adults over 60 with aggressive B-cell lymphoma who cannot handle standard full-dose chemotherapy. The treatment uses three targeted drugs (rituximab, polatuzumab vedotin, and glofitamab) to attack the cancer while reducing side effects. The goal is to see how well this approach controls the disease and improves survival.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LYMPHOMA, LARGE B-CELL, DIFFUSE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
AKH Meduni Wien
Vienna, Austria
-
Charité - Universitätsmedizin Berlin
Berlin, Germany
-
Ev. Klinikum Essen-Mitte
Essen, Germany
-
HELIOS Klinikum Berlin-Buch
Berlin, Germany
-
Hanusch Krankenhaus
Vienna, Austria
-
Kepler Universitätsklinikum
Linz, Austria
-
Klinikum Chemnitz
Chemnitz, Germany
-
Klinikum Ludwigshafen
Ludwigshafen, 67063, Germany
-
Kreiskliniken Reutlingen
Reutlingen, Germany
-
Landeskrankenhaus Salzburg Universitätsklinikum der Paracelsus Medizinischen Privatuniversität
Salzburg, Austria
-
Medizinisches Universitätsklinikum Knappschaftskrankenhaus Bochum
Bochum, Germany
-
Ordensklinikum Linz - Barmherzige Schwestern
Linz, Austria
-
Ordensklinikum Linz - Elisabethinen
Linz, Austria
-
Ortenauklinikum Offenburg-Kehl
Offenburg, Germany
-
TU München (rechts des Isar)
München, Germany
-
Uniklinik Innsbruck
Innsbruck, Austria
-
Uniklinikum Düsseldorf
Düsseldorf, Germany
-
Univ. Klinikum St. Pölten
Sankt Pölten, Austria
-
University Hospital Jena
Jena, Germany
-
Universitätsklinikum Erlangen
Erlangen, Germany
-
Universitätsklinikum Halle
Halle, Germany
-
Universitätsklinikum Leipzig
Leipzig, 04103, Germany
-
Universitätsklinikum Magdeburg
Magdeburg, Saxony-Anhalt, 39120, Germany
-
Universitätsklinikum Regensburg
Regensburg, Germany
-
Universitätsklinikum Schleswig-Holstein Campus Kiel
Kiel, Germany
-
Universitätsklinikum Würzburg
Würzburg, Germany
-
Unversitätsklinikum Münster
Münster, 48149, Germany
-
Westdeutsches Tumorzentrum Essen
Essen, Germany
Conditions
Explore the condition pages connected to this study.